Analyses of the Dual Immune Roles Cytokines Play in Ischemic Stroke

  • Yingying Wang
  • Jianfeng Liu
  • Haibo Yu
  • Yunpeng CaiEmail author
Conference paper
Part of the Lecture Notes in Computer Science book series (LNCS, volume 10594)


Stroke is one of the leading causes of morbidity and permanent disability worldwide. There is a need for an efficacious alternative therapy administered beyond the limitation of time window based on the biological characteristics of stroke, currently. The immunomodulatory therapy could extend the time window while not increase the risk of hemorrhage which made it become candidate treatments. In this paper, we integrated several gene expression profiles generated from the peripheral blood of ischemic stroke patients and health people. Differential expressed cytokines were first selected as candidate cytokines. Enrichment analyses were then performed to filter the candidate cytokines as biomarkers (E-CKs) by checking the relationships between them and the stroke related functional terms. More cytokines were found as biomarkers in the sub-acute stage of ischemic stroke compared with acute and chronic stages which could be explained by the great changes in microenvironment in this necrosis stage. Analyses based on microRNomics level showed that more E-CKs one miRNA regulated, the more important role it played in stroke related processes. Similarly, analyses on proteomics level showed that E-CKs with top degrees in the protein-protein interaction network were proved to be closely related to stroke. Most E-CKs participate in both the stroke processing and rehabilitation, thus, the dual immune characters made them become valuable potential targets of immunomodulatory therapies.


Cytokine Ischemic stroke Dual immune roles 


  1. 1.
    Jiang, Y., Zhu, W., Zhu, J., et al.: Feasibility of delivering mesenchymal stem cells via catheter to the proximal end of the lesion artery in patients with stroke in the territory of the middle cerebral artery. Cell Transplant. 22(12), 2291–2298 (2013)CrossRefGoogle Scholar
  2. 2.
    Lees, K.R., Bluhmki, E., von Kummer, R., et al.: Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials. Lancet 375(9727), 1695–1703 (2010)CrossRefGoogle Scholar
  3. 3.
    Fonarow, G.C., Smith, E.E., Saver, J.L., et al.: Timeliness of tissue-type plasminogen activator therapy in acute ischemic stroke: patient characteristics, hospital factors, and outcomes associated with door-to-needle times within 60 minutes. Circulation 123(7), 750–758 (2011)CrossRefGoogle Scholar
  4. 4.
    Lo, E.H.: Degeneration and repair in central nervous system disease. Nat. Med. 16, 1205–1209 (2010)CrossRefGoogle Scholar
  5. 5.
    Morancho, A., Rosell, A., Garcia-Bonilla, L., et al.: Metalloproteinase and stroke infarct size: role for anti-inflammatory treatment? Ann. N. Y. Acad. Sci. 1207, 123–133 (2010)CrossRefGoogle Scholar
  6. 6.
    Xu, X., Jiang, Y.: The Yin and Yang of innate immunity in stroke. Biomed. Res. Int. 2014, 807978 (2014)Google Scholar
  7. 7.
    Shichita, T., Ago, T., Kamouchi, M., et al.: Novel therapeutic strategies targeting innate immune responses and early inflammation after stroke. J. Neurochem. 123(supplement 2), 29–38 (2012)CrossRefGoogle Scholar
  8. 8.
    Banwell, V., Sena, E.S., Macleod, M.R.: Systematic review and stratified meta-analysis of the efficacy of interleukin-1 receptor antagonist in animal models of stroke. J. Stroke Cerebrovasc. Dis. 18(4), 269–276 (2009)CrossRefGoogle Scholar
  9. 9.
    Gertz, K., Kronenberg, G., Kälin, R.E., et al.: Essential role of interleukin-6 in post-stroke angiogenesis. Brain J. Neurol. 135(6), 1964–1980 (2012)CrossRefGoogle Scholar
  10. 10.
    Zeng, L., Wang, Y., Liu, J., et al.: Pro-inflammatory cytokine network in peripheral inflammation response to cerebral ischemia. Neurosci. Lett. 548, 4–9 (2013)CrossRefGoogle Scholar
  11. 11.
    Cure, M.C., Tufekci, A., Cure, E., et al.: Low-density lipoprotein subfraction, carotid artery intima-media thickness, nitric oxide, and tumor necrosis factor alpha are associated with newly diagnosed ischemic stroke. Ann. Indian Acad. Neurol. 16(4), 498–503 (2013)CrossRefGoogle Scholar
  12. 12.
    Maddahi, A., Kruse, L.S., Chen, Q.W., et al.: The role of tumor necrosis factor-α and TNF-α receptors in cerebral arteries following cerebral ischemia in rat. J. Neuroinflammation 8, 107 (2011)CrossRefGoogle Scholar
  13. 13.
    Yingying, W., Yunpeng, C.: A survey on database resources for microRNA-disease relationships. Brief Funct. Genomics 16(3), 146–151 (2017)Google Scholar
  14. 14.
    Yingying, W., Yunpeng, C.: Obtaining human ischemic stroke gene expression biomarkers from animal models: a cross-species validation study. Sci Rep. 6, 29693 (2016)CrossRefGoogle Scholar
  15. 15.
    Jing, L., Yunpeng, Z., Yingying, W., et al.: Functional combination strategy for prioritization of human miRNA target. Gene 533(1), 132–141 (2014)CrossRefGoogle Scholar
  16. 16.
    Yingying, W., Lei, D., Xia, L., et al.: Functional homogeneity in microRNA target heterogeneity - a new sight into human microRNomics. OMICS J. Integr. Biol. 15(1-2), 25–35 (2011)CrossRefGoogle Scholar
  17. 17.
    Yingying, W., Yunpeng, C.: A network-based analysis of ischemic stroke using parallel microRNA-mRNA expression profiles. In: GlobalSIP14-Workshop on Genomic Signal Processing and Statistics. Atlanta, Georgia, USA, 03–05 December 2014Google Scholar
  18. 18.
    Barrett, T., Wilhite, S.E., Ledoux, P., et al.: NCBI GEO: archive for functional genomics data sets–update. Nucleic Acids Res. 41, D991–D995 (2013)CrossRefGoogle Scholar
  19. 19.
    Stamova, B., Jickling, G.C., Ander, B.P., et al.: Gene expression in peripheral immune cells following cardioembolic stroke is sexually dimorphic. PLoS ONE 9, e102550 (2014)CrossRefGoogle Scholar
  20. 20.
    Barr, T.L., VanGilder, R., Rellick, S., et al.: A genomic profile of the immune response to stroke with implications for stroke recovery. Biol. Res. Nurs. 17, 248–256 (2015)CrossRefGoogle Scholar
  21. 21.
    Krug, T., Gabriel, J.P., Taipa, R., et al.: TTC7B emerges as a novel risk factor for ischemic stroke through the convergence of several genome-wide approaches. J. Cereb. Blood Flow Metab. 32, 1061–1072 (2012)CrossRefGoogle Scholar
  22. 22.
    Fagan, S.C., Hess, D.C., Hohnadel, E.J., et al.: Targets for vascular protection after acute ischemic stroke. Stroke 35(9), 2220–2225 (2004)CrossRefGoogle Scholar
  23. 23.
    Subramanian, A., Tamayo, P., Mootha, V.K., et al.: Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA 102(43), 15545–15550 (2005)CrossRefGoogle Scholar
  24. 24.
    Keshava Prasad, T.S., Goel, R., Kandasamy, K., et al.: Human protein reference database–2009 update. Nucleic Acids Res. 37, D767–D772 (2009)CrossRefGoogle Scholar
  25. 25.
    Chou, C.H., Chang, N.W., Shrestha, S., et al.: miRTarBase 2016: updates to the experimentally validated miRNA-target interactions database. Nucleic Acids Res. 44, D239–D247 (2016)CrossRefGoogle Scholar
  26. 26.
    Liu, F.J., Kaur, P., Karolina, D.S., et al.: MiR-335 Regulates Hif-1α to reduce cell death in both mouse cell line and rat ischemic models. PLoS ONE 10(6), e0128432 (2015)CrossRefGoogle Scholar
  27. 27.
    Zhang, H., Liu, L., Hu, J., et al.: MicroRNA regulatory network revealing the mechanism of inflammation in atrial fibrillation. Med. Sci. Monit. 14(21), 3505–3513 (2015)CrossRefGoogle Scholar
  28. 28.
    Rainer, T.H., Leung, L.Y., Chan, C.P., et al.: Plasma miR-124-3p and miR-16 concentrations as prognostic markers in acute stroke. Clin. Biochem. 49(9), 663–668 (2016)CrossRefGoogle Scholar
  29. 29.
    Wen, Y., Zhang, X., Dong, L., et al.: Acetylbritannilactone modulates MicroRNA-155-Mediated inflammatory response in ischemic cerebral tissues. Mol. Med. 18(21), 197–209 (2015)Google Scholar
  30. 30.
    Wang, Y., Dong, X., Li, Z., et al.: Downregulated RASD1 and upregulated miR-375 are involved in protective effects of calycosin on cerebral ischemia/reperfusion rats. J. Neurol. Sci. 339(1–2), 144–148 (2014)CrossRefGoogle Scholar
  31. 31.
    Liu, X.L., Du, J.Z., Zhou, Y.M., et al.: Interleukin-16 polymorphism is associated with an increased risk of ischemic stroke. Mediators Inflamm. 2013, Article ID 564750 (2013)Google Scholar
  32. 32.
    Mostafa, M.A., El-Nabiel, L.M., Fahmy, N.A., et al.: ACE gene in Egyptian ischemic stroke patients. J. Stroke Cerebrovasc. Dis. 25(9), 2167–2171 (2016)CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  • Yingying Wang
    • 1
    • 2
  • Jianfeng Liu
    • 3
  • Haibo Yu
    • 4
  • Yunpeng Cai
    • 1
    • 2
    Email author
  1. 1.Research Center for Biomedical Information Technology, Shenzhen Institutes of Advanced TechnologyChinese Academy of SciencesShenzhenChina
  2. 2.Shenzhen Engineering Laboratory of Health Big Data Analyses TechnologyShenzhenChina
  3. 3.Department of NeurologyThe First Affiliated Hospital of Harbin Medical UniversityHarbinChina
  4. 4.Shenzhen Traditional Chinese Medicine HospitalShenzhenChina

Personalised recommendations